secwatch.observer — SEC 8-K summary
======================================

Issuer:     Orthofix Medical Inc. (OFIX)
CIK:        0000884624
Form:       8-K
Filed at:   2022-10-11T23:59:59+00:00
Accession:  0001193125-22-260160
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Orthofix reports Q3 preliminary net sales $114M, up 5% CC; announces SeaSpine merger
--------------------------------------------------------------------------------

- Preliminary Q3 net sales $114M, +1% reported, +5% constant currency YoY; nine-month net sales $339M, flat reported.
- Global Orthopedics grew 19% CC; Biologics +8% CC; Bone Growth Therapies +3% CC; Spinal Implants -7% CC.
- Preliminary cash, cash equivalents and restricted cash ~$52M as of Sep 30, 2022.
- Entered all-stock merger of equals with SeaSpine (NASDAQ: SPNE) to create leading spine and orthopedics company.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/884624/000119312522260160/0001193125-22-260160-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/884624/000119312522260160/d407558d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-260160

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer